Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Payables (2016 - 2026)

Rockwell Medical filings provide 16 years of Payables readings, the most recent being $2.3 million for Q4 2025.

  • On a quarterly basis, Payables fell 27.86% to $2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 million, a 27.86% decrease, with the full-year FY2025 number at $2.3 million, down 27.86% from a year prior.
  • Payables hit $2.3 million in Q4 2025 for Rockwell Medical, up from $2.0 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $6.7 million in Q2 2023 to a low of $2.0 million in Q3 2025.
  • Median Payables over the past 5 years was $4.2 million (2021), compared with a mean of $4.0 million.
  • Biggest five-year swings in Payables: skyrocketed 49.63% in 2023 and later crashed 59.5% in 2025.
  • Rockwell Medical's Payables stood at $4.2 million in 2021, then rose by 9.1% to $4.6 million in 2022, then grew by 4.48% to $4.8 million in 2023, then plummeted by 34.1% to $3.1 million in 2024, then fell by 27.86% to $2.3 million in 2025.
  • The last three reported values for Payables were $2.3 million (Q4 2025), $2.0 million (Q3 2025), and $2.2 million (Q2 2025) per Business Quant data.